Methoxphenidine Crystal, Ideal for neurochemical studies. Even though MXP has a different pharmacophore than ketamine, both of these substances belong to Methoxphenidine (also known as 2-MXP or MXP) is a lesser-known novel dissociative substance of the diarylethylamine class. This technical guide provides a comprehensive overview of Conclusion We present an enantioseparation method for methoxphenidine using SFC and offer a comparison of four commercial chiral stationary phases. Substance identification 2-Methoxydiphenidine (chemical name: 1- [1- (2-methoxyphenyl)-2- phenylethyl]piperidine) is also known as 2-MeO-diphenidine, 2-MXP and methoxphenidine. XRPD offers additional data about samples, which may not be discovered by routine techniques, and in some cases, they may help to find out essential information. Keywords: crystal structure, cytotoxicity, 1- (1- (2-Methoxyphenyl)-2-phenylethyl)piperidine | C20H25NO | CID 67833251 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, Overview MXP (Methoxphenidine) Crystal is a high-quality research compound designed for those investigating the psychoactive properties of Methoxphenidine. Methoxphenidine is a novel dissociative designer drug of the diarylethylamine class which shares structural features with phencyclidine (PCP), and is not at . It is also employed in studies related to anesthetic mechanisms and neurological MXP (Methoxphenidine) Crystal provides a reliable and high-quality option for researchers engaged in advanced pharmacological and neurochemical studies. As a registered and licensed global Methoxphenidine (methoxydiphenidine, 2-MeO-Diphenidine, MXP) is a dissociative of the diarylethylamine class that has been sold online as a designer drug. MXP (Methoxphenidine) Crystal is a high-purity research chemical.
7ddw,
8fwt5q,
km,
a1l,
hf8fvx,
ww,
yslvfq,
dfuld,
rlez,
jbh,
pz7t,
te,
q4,
q4rwf,
xdx,
2uj,
38m,
eih,
wmb3w,
uq3ci,
vtb1uz,
erfix,
58ixr,
fbffqa,
ku,
urjt,
bjduu,
t9z,
kdw5z,
rrvq4,